ORBIMED ADVISORS LLC Longboard Pharmaceuticals, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$422,000
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+20.39%
quarter

Longboard Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 71K $3.72 113.5K
Q2 2022 share 0.00% 0 shares -255K $3.09 113.5K
Q1 2022 share 0.00% 0 shares 52K $5.34 113.5K
Q4 2021 share 0.00% 0 shares -450K $4.75 113.5K
Q3 2021 share 0.00% 0 shares -31K $8.85 113.5K
Q2 2021 share Decrease -62.17% -186.5K shares -3.87M $9.12 113.5K
Q1 2021 share Increase 0.00% 300K shares 4.91M $16.38 300K